Peppermint oil and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Peppermint oil (peppermint) and Gliclazide (gliclazide). Common drug interactions include antipsychotic drug level increased among females and chest discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Peppermint oil and Gliclazide. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Peppermint oil?

Peppermint oil has active ingredients of peppermint. eHealthMe is studying from 1,061 Peppermint oil users. Check the latest studies of Peppermint oil.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

On Aug, 07, 2026

26 people who take Peppermint oil and Gliclazide together, and have interactions are studied.

Peppermint oil and Gliclazide drug interactions.

What are the common drug interactions of Peppermint Oil and Gliclazide, by gender? *:

female:

Antipsychotic drug level increased
Drug level increased
Lower respiratory tract infection
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Respiratory disorder (respiratory disease)
Respiratory tract infection
Enteritis (inflammation of the small intestine)
Herpes zoster
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Asthma

male:

Chest discomfort
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Influenza like illness
Myalgia (muscle pain)
Pain in extremity
Peripheral ischaemia (impaired circulation to an extremity)

What are the common drug interactions of Peppermint Oil and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cardiac arrest
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Antipsychotic drug level increased
Drug level increased
Lower respiratory tract infection
Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
Respiratory disorder (respiratory disease)
Respiratory tract infection
Asthma

50-59:

n/a

60+:

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Lactic acidosis (low ph in body tissues)
Enteritis (inflammation of the small intestine)
Chest discomfort
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Influenza like illness
Myalgia (muscle pain)
Pain in extremity
Peripheral ischaemia (impaired circulation to an extremity)

What are the existing conditions these people have? *

Pain: 16 people, 61.54%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 19.23%
Rashes (redness): 5 people, 19.23%
Oral Candidiasis (fungal infection of mouth): 5 people, 19.23%
Laxative Supportive Care: 5 people, 19.23%
Breast Cancer: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Peppermint oil and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously